Selank

Evidence Limitation: The provided research does not contain any studies specifically examining Selank's safety profile, side effects, contraindications, or drug interactions. The available evidence consists entirely of unrelated studies on topics such as nutrient management, plant biology, and other medical conditions that do not involve Selank.

Available Safety Information: Based on the provided evidence, no specific safety data for Selank can be reported. Information on the following critical safety aspects is not available in the current evidence base:

• Known side effects or adverse reactions
• Contraindications for use
• Drug interactions
• Special populations who should avoid Selank
• Dosing safety parameters
• Long-term safety data

Clinical Trial Safety Data: The provided clinical trials (NCT01747200 and NCT05832060) investigate transcranial magnetic stimulation and brain stimulation techniques for cognitive disorders, not Selank administration, and therefore provide no relevant safety information for this compound.

Recommendation: Given the complete absence of Selank-specific safety data in the provided evidence, healthcare providers and patients would need to consult additional peer-reviewed literature and clinical studies specifically designed to evaluate Selank's safety profile before making any clinical decisions.

Disclaimer: This safety assessment is based solely on the limited evidence provided and does not constitute medical advice. Consult with a qualified healthcare provider before considering any therapeutic intervention.